Schmidt & Clark, LLP Announces Launch of Topamax Birth Defects Website

Schmidt & Clark, LLP Announces Launch of Topamax Birth Defects Website The U.S. Food & Drug Administration (FDA) recently issued a safety warning regarding the increased risk of birth defects in babies born to mothers that took Topamax during pregnancy. Specifically, Topamax has been linked to cleft lip and/or cleft palate (oral clefts), cranial malformations, genital malformations and other serious birth defects. Washington, DC (PRWEB) March 13, 2011 Schmidt & Clark, LLP, a nationally recognized products liability law firm, announced today that it has recently launched a n
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations